Odyssey Health (ODYY) Net Cash Flow Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 35.53% |
| Oct 31, 2025 | -50.98% |
| Jul 31, 2025 | -15.23% |
| Apr 30, 2025 | -16.73% |
| Jan 31, 2025 | 14.06% |
| Oct 31, 2024 | 22.82% |
| Jul 31, 2024 | -18.95% |
| Apr 30, 2024 | -219.44% |
| Jan 31, 2024 | -142.82% |
| Oct 31, 2023 | 204.51% |
| Jul 31, 2023 | 52.30% |
| Apr 30, 2023 | -51.66% |
| Jan 31, 2023 | -5.74% |
| Oct 31, 2022 | -63.31% |
| Jul 31, 2022 | 81.91% |
| Apr 30, 2022 | 91.80% |
| Jan 31, 2022 | -116.64% |
| Oct 31, 2021 | -122.38% |
| Jul 31, 2021 | -167.74% |
| Apr 30, 2021 | 83.40% |
| Jan 31, 2021 | -122.22% |
| Oct 31, 2020 | 249.13% |
| Jul 31, 2020 | 110.42% |
| Apr 30, 2020 | 22.93% |
| Jan 31, 2020 | -58.11% |
| Oct 31, 2019 | -319.26% |